Alan Swann Selected Research

Quetiapine Fumarate (Seroquel)

4/2005	Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
12/2004	Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan Swann Research Topics

Disease

3	Dementia (Dementias) 04/2005 - 02/2002
2	Alzheimer Disease (Alzheimer's Disease) 04/2005 - 01/2004
1	Treatment-Resistant Depressive Disorder 03/2011
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2006
1	Mania (Manias) 01/2006
1	Cognitive Dysfunction 04/2005
1	Schizophrenia (Dementia Praecox) 12/2004
1	Stroke (Strokes) 01/2004
1	Language Disorders (Language Disorder) 02/2002

Drug/Important Bio-Agent (IBA)

2	Quetiapine Fumarate (Seroquel)FDA Link 04/2005 - 12/2004
2	Antipsychotic Agents (Antipsychotics)IBA 01/2004 - 02/2002
1	Antidepressive Agents (Antidepressants)IBA 03/2011
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2006
1	Rivastigmine (Exelon)FDA LinkGeneric 04/2005
1	Olanzapine (Zyprexa)FDA Link 12/2004
1	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2004
1	Indicators and Reagents (Reagents)IBA 01/2004